FINWIRES · TerminalLIVE
FINWIRES

オッペンハイマーは、アカマイ・テクノロジーズの第1四半期売上高が予想を上回るとの見通しを示した。

-- オッペンハイマーは木曜日、アカマイ・テクノロジーズ(AKAM)の第1四半期の売上高がガイダンスの上限に達し、平均契約規模が前年同期比で中一桁台の伸びを示す見込みだと発表した。 大型契約の増加は、GuardicoreとNonameのセキュリティモジュールおよびクラウドインフラストラクチャ機能の採用拡大によるものだ。オッペンハイマーは、2026年までにGuardicoreの採用が少なくとも25%、Nonameが65%増加し、セキュリティポートフォリオ全体の成長率が少なくとも10%になると予測している。 エージェント型ウェブはアカマイにとって大きなチャンスとなる。同社のAPIセキュリティは「クラス最高」と評価されており、マルチコンテンツ配信ネットワーク環境において優位性を確立している。また、エージェントの普及は配信とコンピューティングの両方に恩恵をもたらすと、同レポートは指摘している。 投資会社オッペンハイマーは、事業基盤の強さ、最近の価格引き上げ、そして下半期におけるエージェント型AI事業の成長見込みを考慮すると、アカマイは通期売上高ガイダンスの上限である8%を容易に達成し、第4四半期には9~10%の成長に加速する可能性があると述べた。 同社は5月7日に第1四半期決算を発表する予定だ。 オッペンハイマーはアカマイの投資判断を「アウトパフォーム」に据え置き、目標株価を115ドルから130ドルに引き上げた。

Price: $95.48, Change: $-1.63, Percent Change: -1.68%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB